http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554362-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106554362-B |
| titleOfInvention | It is a kind of using 1- pyridines-B-carboline as copper chloride (II) chelate and its synthetic method of ligand and application |
| abstract | The invention discloses a kind of using 1 pyridine β carbolines as copper chloride (II) chelate and its synthetic method of ligand and application.Shown in the structural formula such as following formula (I) of copper chloride (II) chelate, preparation method is：Take compound and Copper dichloride dihydrate as shown in following formula (II), be dissolved in polar solvent, carry out complexation reaction to get.Copper chloride (II) chelate of the present invention shows antitumor activity more stronger than ligand and cis-platinum, has preferable potential medical value, is expected to be used for the preparation of various antitumor drugs.Structure shown in formula (I) and formula (II) is as follows： |
| priorityDate | 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.